Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1

Similar documents
Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1

NIH Public Access Author Manuscript Traffic Inj Prev. Author manuscript; available in PMC 2012 April 1.

Higher levels of hair EtG in patients with decreased kidney function.

2/12/2019. Direct biomarkers of alcohol consumption in professionals health programs. Objectives. IPN/PRN Annual Conference and Evaluator Training

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L.

ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS

Detection of the Direct Alcohol Biomarker Ethyl Glucuronide (EtG) in Hair An Annotated Bibliography

Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair

Alcohol Biomarkers. BMF 77 - Alcohol Biomarkers

DRUG & ALCOHOL TESTING YOUR QUESTIONS ANSWERED

Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption?

Biomarkers, alcohol and health: recognizing the switch from moderation to abuse

Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets)

THCCOOH and ETG in hair: analytical challenges and interpretation of results in Forensic Toxicology. Luca Morini

Application of phosphatidylethanol (PEth) in whole blood in comparison to ethyl glucuronide in hair (hetg) in driving aptitude assessment (DAA)

Biological markers for abuse and addiction

Progress has been achieved but there is more work to do

HAIR ALCOHOL TESTING EtG

Drink Driving in Finland Petri Jääskeläinen

NIH Public Access Author Manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2011 March 1.

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Alcoholism markers in their relation to prevention and rehabilitation

Trends in Impaired Driving in the United States: How to Resume Progress

Gamma-glutamyl Transpeptidase Activity Among Convicted Multiple DUI Offenders

Alcohol-Related Crashes Alcohol Overview

Current New Zealand BAC Limit. BAC (mg/100ml)

Richmond London Borough Council v B, W, B and CB [2010] EWHC 2903 (Fam)

The Difficulty of using a Biological Marker for Alcohol Use: A Recent

Evaluation and clinical application of ethyl glucuronide and ethyl sulfate as biomarkers for recent alcohol consumption

Alcohol & Drugs. Contents:

Kentucky DUI Assessment Report for 2003

Alcohol and Drug Consumption by Québec Truck Drivers

Substance consumption and willingness to drive a comparison of illegal drugs and alcohol

ORIGINAL INVESTIGATION. Screening for Alcohol Problems in Primary Care

Federal agency says urine-alcohol test isn't totally reliable

Grand Rapids Effects Revisited: Accidents, Alcohol and Risk

Guidelines for Sentencing DUI Offenders in the United States

9/22/2015. Timothy W. Lineberry, MD Chief Medical Officer Greater Green Bay Aurora Health Care

This item is the archived peer-reviewed author-version of:

Berks County Treatment Courts

Stability of Phosphatidylethanol in Dry Blood Spot Cards

Towards a national model for managing impaired driving offendersadd_

Worldwide Trends in Drinking and Driving: Has the Progress Continued?

MEASUREMENT OF CARBOHYDRATE-DEFICIENT TRANSFERRED (CDT) IN A GENERAL MEDICAL CLINIC: IS THIS TEST USEFUL IN ASSESSING ALCOHOL CONSUMPTION?

OECD Paris, September 2008

Road Safety Authority Annual International Road Safety Conference

Strategy in the Use of Biological Markers. in Regranting of Driving Licences

Drink driving strategies in Denmark. Pernille Ehlers

Best Practices Review Drug & EtG/EtS Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant

DUI Arrests, BAC at the Time of Arrest and Offender Assessment Test Results for Alcohol Problems

Comparison of Multiple DUI Offenders Selecting Either Antabuse or 12-Step Treatment Programs

Alcohol Related Cognitive Deficits Amongst Pilots in Early Recovery. Bruce Figuered, Ph.D. Gary Kay, Ph.D.

Biomarkers for Underreported Alcohol Use

Fit to Drive: A European view on Traffic Safety

Research Says Best Practices in Assessment, Management and Treatment of Impaired Drivers. NADCP July 28, 2015

24/7 sobriety program THE MONTANA STORY

CONCENTRATION OF FATTY ACID ETHYL ESTERS IN HAIR OF ALCOHOLICS: COMPARISON TO OTHER BIOLOGICAL STATE MARKERS AND SELF REPORTED-ETHANOL INTAKE

Transdermal Alcohol Monitoring (TAM) in compliance with abstinence: Records from 250,000 offenders in the United States

Alcohol-impaired driving in the lab: Efforts to reduce the incidence of drinking and driving

METHOD-DEPENDENT CHARACTERISTICS OF CARBOHYDRATE-DEFICIENT TRANSFERRIN MEASUREMENTS IN THE FOLLOW-UP OF ALCOHOLICS

Adulterated Diluted samples will be treated as a Drug Court Sanction.

The Promise of DWI Courts November 14, 2013 Judge J. Michael Kavanaugh, (Ret.) Senior Director NCDC Judge Kent Lawrence, (Ret.)

Emerging Biomarkers of Alcohol Consumption: Clinical and Forensic Applications

Putative Mechanisms Underlying Risky Decision-Making in High Risk Drivers

A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri

Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000

The Uganda ARCH Cohort study is observational and seeks to determine the effect of alcohol consumption on HIV disease progression prior to ART.

DRINKING-DRIVING CHARACTERISTICS OF DRINKING DRIVERS M.W. Bud Perrine Vermont Alcohol Research Center Burlington, Vermont USA

The Worldwide Decline in Drinking and Driving

SCREENING OF ARRESTED DRUNKEN DRIVERS FOR ALCOHOLISM. 1 2 J. Pikkarainen and A. Penttila

Poor impulse control and heightened attraction to alcohol-related imagery in repeat DUI offenders

2016 MATCP Conference. Research Says Best Practices in Assessment, Management, and Treatment of Impaired Drivers. Mark Stodola Probation Fellow

ROAD SAFETY MONITOR. ALCOHOL-IMPAIRED DRIVING IN THE UNITED STATES Results from the 2018 TIRF USA Road Safety Monitor

Blood Alcohol Levels for Fatally Injured Drivers

State Epidemiological Outcomes Workgroup

2. Chapter 2: Eligibility

Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash

ALCOHOL DRUG EVALUATION PREPARATION

Characteristics and Predictors of Recidivist Drink-Drivers

EVALUATION OF A DRUNK DRIVING WARNING SYSTEM. * A. Bodi, Ph.D.; R. E. O'Connor, Ph.D.; and M. J. King, B.Sc. (Hons), M.A.P.S.

Impaired Driving: Progress and Challenges

BLOOD ALCOHOL LEVELS FOR FATALLY INJURED DRIVERS

Review of Drug Impaired Driving Legislation (Victoria Dec 2000) and New Random Drug Driving Legislation Based on Oral Fluid Testing

Review Article. Ethyl glucuronide. Natalie E Walsham 1 and Roy A Sherwood 2

The future s bright, the future s orange. the challenges of liver disease now and in the next 50 years

IN 1984, AFTER a significant period of planning and preparation,

Collisions Of Alcohol, Cannabis And Cocaine Abuse Clients Before And After Treatment

epic.org EPIC WI-FOIA Production epic.org/algorithmic-transparency/crim-justice/

Underwriting the Habits Risk of Alcohol Use Gregory Ferrara New York Life Underwriting January, 2013

Modifications to Traffic Signal Operation to Improve Safety for Alcoholaffected

EUROPEAN ALCOHOL CONSUMPTION QUESTIONNAIRE FOR EHIS WAVE II June 1, 2011

Reliability of lifetime drinking history among alcoholic men

Assessment of Alcohol Consumption in Liver Transplant Candidates and Recipients: The Best Combination of the Tools Available

Investigation of HAZARDOUS DRINKING. 2 November 2010 best tests

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

An Evaluation of the High Risk Offender Scheme

Mark Stodola & Erin Holmes Louisiana Association of Drug Court Professionals Conference April 5, 2018 New Orleans, Louisiana

Alcohol Testing - What are the options?

Alberta Alcohol and Drug Abuse Commission. POSITION ON EMPLOYMENT-RELATED ALCOHOL AND DRUG TESTING November 2006

Transcription:

Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1 Paul R. Marques 1 A. Scott Tippetts 1 Michel Yegles 2 1 Pacific Institute for Research and Evaluation 11720 Beltsville Dr., Suite 900, Calverton, MD USA 20705 2 Laboratoire National de Santé, Toxicologie, Université du Luxembourg, 162a, av. Faïencerie, L-1511 Luxembourg Abstract Background Ignition interlocks reduce recidivism while installed, a benefit lost once devices are removed. Iinterlock BAC test fail rates predict this post-interlock recidivism. Various alcohol biomarker types, sourced from urine, blood and hair predict interlock fail rates. Which biomarkers best predict recidivism and which would be the best components in a panel of markers to help evaluate drink-driving offenders? Aims The aim is to characterize risk indicators and outcomes among interlock participants. This paper focuses on new analyses comparing different marker types in prediction of 4 categories of criterion correlates or outcomes: recidivism, alcohol dependence, ordinal fail rates, maximal BAC attained during the first two interlock months. Methods Interlock offenders gave consent and interviews (for DSM4 diagnosis), self-report assessments (DRINC, AUDIT, TLFB) and contributed blood, hair, urine for analysis of GGT, MCV, ALT, AST, PEth-HPLC, PEth-LCMSMS, uetg, hetg, uets, hfaee, %CDT, γ%cdt. ROC analysis of interlock BAC test records and driver records yielded predictor and outcome variables. Results Hair EtG was the strongest predictor of baseline alcohol dependence and subsequent recidivism; it shared honors with PEth for predicting maximal recorded levels of BAC. PEth was the strongest predictor of failed BAC tests across 5 ordinal combinations of failed BAC tests, both overall and morning tests. γ%cdt was the best indirect marker. TLFB drinks per drinking day was the only interesting non-biomarker predictor. Hair EtG above either the 30 pg/mg cutoff (2/3 of drivers above) or the 50 pg/mg (1/3 of drivers above) is strongly associated with other selfreport, diagnostic and interlock-based indicators of alcohol driving risk. Discussion PEth and hair EtG are the two best component alcohol biomarkers to include in a comprehensive monitoring panel for driver alcohol risk. Hair EtG overlaps little with other alcohol biomarkers in explaining variance. GGT and %CDT, while weaker, are the best indirect markers. 1 Supported by NIAAA Research Grants R01 AA014206 and R21 AA019696 Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1

Introduction Interlock BAC test fail rates predict post-interlock recidivism. Various alcohol biomarker types, both direct and indirect sourced from urine, blood, and hair, predict interlock fail rates. This paper provides new analyses comparing different marker types in prediction of 4 criteria or outcomes: new recidivism, alcohol dependence, morning plus overall fail rates, and maximal BAC attained during the first two interlock months. Marques et al., (2010) reported that the average levels of six different alcohol biomarkers: phosphatidylethanol (PEth), gamma glutamyltransferase (GGT), percent carbohydrate deficient transferrin (%CDT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), macrocytic volume (MCV), measured at the start and the end of a period of interlock controlled driving, were largely unchanged (at the group level) over the mean 8 intervening months. Despite recidivism reductions, and an aggregate 50% reduction in rates of failed BAC test logged on the interlock device, drinking levels held constant during the interlock period even while drinking-driving declined by 2/3 (based on recidivism data). Declining recidivism and BAC test failures during the interlock had for some years been viewed as evidence of a reduction in drinking. The biomarker data suggests that view was premature. An estimate of drinking proclivity would be useful before a driver is released from an interlock program. The BAC test fail rates from the interlock record are one source of information, but exclusive reliance on it could easily encourage actively monitored drivers to avoid the interlock car toward the end of the required time. Alcohol biomarkers are endogenous to the individual and so cannot be easily gamed, but there are many markers to choose from. What might be the best alcohol biomarkers for estimating drinking proclivity near the end of an interlock program? The ability to anticipate driver risk based on the pattern of interlock BAC test fail rates has led several state governments to extend interlock time for these higher risk drivers. This is sensible policy, but it leaves unanswered the question: what explains the rapid reversion to control levels of recidivism once the interlocks are removed? Having attained some degree of accommodation to drinking AND driving, why would drivers change, and what do they change? Blood and urine alcohol biomarkers can extend the surveillance window to detect drinking for several days to weeks or more after significant consumption. Direct alcohol biomarkers (PEth, EtG, EtS, FAEE) are ethanol itself, products of minor ethanol metabolic pathways, or are produced only in the presence of alcohol; since these directly reflect alcohol exposure they have higher sensitivity and specificity than indirect markers. Indirect markers, often thought of as disease markers, include (GGT, MCV, ALT, AST, CDT); these are liver enzymes, blood products, or physiologic reactions that occur after regular high levels of alcohol exposure. Some alcohol biomarkers can be measured in hair (due to uptake and sequester from blood in the hair follicles) and extend the detection period to several months of past alcohol consumption. Høiseth et al. (2009) noted that hetg shows the highest sensitivity relative to traditional biomarkers with levels proportional to the alcohol consumed. Pirro et al. (2011) reported hetg to be the most accurate biomarker for the identification of heavy drinking. Liniger et al. (2010) concluded that hetg is the best choice for assessing fitness in suspected drinking drivers. Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 2

The Society of Hair Testing (SoHT), concluded that 30 picograms of EtG per milligram of hair, estimated to grow 1 cm/month, is consistent with abuse levels of alcohol consumption. Dufaux et al. (2012) analyzed samples from German drivers seeking to reinstate driver licenses and found that the measurement of EtG in hair, with its longer time horizon, detected 12.7% positives relative to 2.1% positives found with the measurement of EtG in urine, a 6-fold detection improvement. These are stable findings based on sample sizes of 4000 and 13,000, respectively. Methods Subsequent to a DUI conviction, 534 interlock offenders (87% male, age 38.6 ± 12, 64% first offenders) signed informed consent documents, sat for interviews, and provided blood, hair and urine for alcohol biomarker determinations. The project was conducted in Edmonton, Alberta, Canada, at the Guardian Interlock Center. Interlock company employees had no role in the research, and research staff had no role in the interlock business. New analyses reported here complement and extend preliminary results previously published (Marques, et al., 2010b). Key assessments included the Timeline Followback (TLFB), Alcohol Use Disorders Inventory (AUDIT), the Drinkers Inventory of Consequences (DRINC), and the DIS-C (Diagnostic Interview Schedule) for DSM-4 diagnoses of Alcohol Dependence and Alcohol Abuse. Interlock data and biological markers Interlock performance data were based on BAC tests during the mean 8 months of interlock program participation; the average driver contributed 2800 BAC tests. With minor exceptions, interlock BAC test data were available on all participants. Not all enrollees were willing to provide blood and other biological specimens. 12 different alcohol biomarkers, or analysis types, were measured at baseline or calculated from baseline data. Six of the alcohol biomarkers were indirect markers, the other six analyses were for direct markers. The latter include PEth measured by HPLC (high performance liquid chromatography) and a subset of those samples was also measured for PEth by LCMSMS (liquid chromatography tandem mass spectroscopy). Others include hair FAEE, urine EtG, urine EtS (ethyl sulfate), and hair EtG. Six blood source biomarkers (GGT, %CDT, PEth, AST, ALT, MCV) were available for 300 participating subjects at baseline (range 298-302). Another, gamma %CDT, was calculated as a log combination of GGT and %CDT, based on Finnish research in which gamma %CDT (γ%cdt)= [0.8 ln(ggt) + 1.3 ln(%cdt)]. Other markers, including hair EtG were added to the panel after the start of the study. 146 subjects provided hair for EtG measurement. Measurements were performed by colleagues in laboratories in the US, Germany, Luxembourg, and Sweden. Statistical analyses Sensitivity analyses of 4 categories of criterion variables were made by calculating A, which represents the area under the ROC curve, ranges from 0.0 to 1.0, and summarizes sensitivity points at various specificities. Each point on the ROC curve measures a sensitivity level (on the y-axis) vs. 1-specificity (on the x-axis) that jointly produces the decision criterion as a predictor is varied. Using lower cutoff values of predictor variables results in greater sensitivity but less specificity; using higher cutoff thresholds provides greater specificity but less sensitivity. Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 3

A new fail rate variable is defined as a 5 level ordinal combination (combo5) of two types of BAC test failures: total fail rate and morning fail rate. Combo5 reflects both overall fail rate and fails that specifically occur in the morning hours of 6-10 AM (Monday through Friday and 8 AM-12 noon Saturday and Sunday) that reflect prior night drinking. The maximal BAC levels (maxbac) recorded on the interlock device during the first 2 program months is analyzed as dichotomous splits; the A values represent 5 different comparisons with increasingly higher fail maxima (BAC results above and below.05,.06,.08,.10, and.12 g/dl). These cutoffs begin as a contrast between the 67% with BAC maxima below.05 and the 33% of participants with maxima of.05 g/dl and above. The series ranges up toward a comparison of the 95% below and the top risk 5% subset with BAC maxima of.12 g/dl and above. Also included in the ROC analyses are two dichotomous variables: new DUI events (recidivism) that occur after beginning the interlock study program, and program entry DSM-IV diagnoses of alcohol dependence (DSM dependence). 36 new DUI recidivist events among 34 participants were logged after interlock installation at a mean of 798 days, about 26 months after program entry (median 775 days, range 177-1563 days). Whether or not there was a new DUI, the duration of time following interlock installation ranged from 344 to 1602 days of data. Participant intakes proceeded continuously over 4 project years. 39% of the sample met criteria for alcohol dependence. Results The point estimates of recidivism prediction by 8 alcohol biomarkers along with pre-program prior DUI and three sensitive indicators from the TLFB interview are shown in Figure 1. Hair EtG was a substantially more sensitive predictor of recidivism (A =.7) than other test variables. 0.75 0.7 0.65 0.6 0.55 0.5 0.45 A' ROC Figure 1: Sensitivity (A ) of predictors of post-installation recidivism Alcohol dependence is a valid alcohol risk factor. Figure 2 shows the point estimates associated with detection of an alcohol dependence diagnosis from the DSM-4 with all 12 biomarkers and other predictor variables. Here hetg along with, uets and the TLFB measure, maximal drinks per drinking day, were all associated with entry dependence diagnoses (A =.67). However, since drinking level (max drinks) influences the dependence diagnosis, the self-report and the diagnosis are not independent. The LCMSMS PEth in Figure 2 also shows high sensitivity. Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 4

0.7 0.65 0.6 0.55 0.5 0.45 A' ROC Figure 2: Sensitivity (A ) of predictors of entry level of alcohol dependence Figure 3 shows hetg and PEth to be the most sensitive predictors of the highest BAC tests recorded during the first 2 months of interlock (A >.69). The chart does not show sensitivity at the highest specificity, BAC.12 g/dl. At that level, hair EtG had A =.776, the highest found. 0.75 0.7 0.65 0.6 0.55 0.5 0.45 Figure 3: Sensitivity (A ) of predictors of mean maximal BAC tests (average.05-.12 g/dl) The sensitivity of the predictors of the combined fail rate criterion (combo5) is not shown but the results are concordant with those reported earlier. The fail rate measures were more successfully detected by PEth (either method: A.72) than hetg (A =.62). In that analysis, γ%cdt was also a sensitive indicator of the average of all BAC fail rates (A =.71). Hair EtG levels are not strongly correlated with other alcohol biomarkers. At a sample split of 30 pg/mg (the SOHT cutoff for heavy drinking) 2/3 of the drivers are above it. At 50 pg/mg, 1/3 of drivers exceed the split. The high hetg subsets have many other risk indicators such as TLFB self-reported consumption, dependence, and interlock-based indicators of alcohol driving risk. Discussion Earlier, we showed PEth was the best overall biomarker for predicting interlock BAC test failure rate, the best correlate of 9 other concurrently measured biomarkers, and the best correlate of self-report assessments about alcohol consumption and consequences in the TLFB, AUDIT, and Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 5

DRINC. In the ROC analyses here, the levels of EtG in hair were found to be a top predictor of criterion variables including: future recidivism, DSM4 alcohol dependence, and maximal BAC attained during the initial two months with an interlock. The direct markers (PEth, EtG) yielded more sensitive and specific ways to predict driver alcohol risk variables than did the indirect markers. Also, the number of prior DUI convictions, ordinarily one of the strongest indicators of driver risk, underperformed nearly all of the alcohol biomarker variables for predicting recidivism, dependence, fail rates, or maximal BACs. Since hair EtG is not strongly correlated with the blood or urine markers concurrently studied, but still predicts driver drinking behavior, it is a good component in a panel of markers; each panel element ideally contributes unique variance. These results and our prior analyses of alcohol biomarkers suggest both hair EtG and blood PEth warrant inclusion as core parts of any alcohol biomarker panel for DUI drivers. We also know that the highest risk DUI drivers have only somewhat lower biomarker levels than do non-residential alcohol treatment patients (Marques, 2012). Few laboratories measure total PEth. However, the detection of non-zero, low levels of PEth in blood via measurement of the dominant subtype of PEth via LCMSMS (Marques et al., 2011) may make possible more widespread use of this method to enhance road safety. References Dufaux, B., Agius, Ronald, Nadulski, T., & Kahl, H-G. (2012). Comparison of urine and hair testing for drugs of abuse in the control of abstinence in driver's license re-granting. Drug Testing and Analysis, published online. doi: 10.1002/dta.400 Høiseth, Gudrun, Morini, Luca, Christophersen, Asbjørg, & Mørland, Jørg. (2009). Ethyl glucuronide in hair compared with traditional alcohol biomarkers A pilot of heavy drinkers referred to an Alcohol Unit. Alcoholism: Clinical and Experimental Research, 33(5), 812-816. Liniger, Bruno, Nguyen, Ariane, Friedrich-Koch, Adrea, & Yegles, Michel. (2010). Abstinence monitoring of suspected drinking drivers: Ethyl glucuronide in hair versus CDT. Traffic Injury Prevention, 11(2), 123-126. doi: 10.1080/15389580903518280 Marques, Paul, Hansson, Therese, Isaksson, Anders, Walther, Lisa, Jones, Joseph, Lewis, Douglas, & Jones, M. (2011). Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Injury Prevention, 12(2), 136-141. Marques, Paul R. (2012). Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems. Drug Testing and Analysis, 4(2), 76-82. Marques, Paul, Tippetts, Scott, Allen, John, Javors, M., Alling, C., Yegles, M., Pragst, F., & Wurst, F. (2010). Estimating driver risk using alcohol biomarkers, interlock BAC tests, and psychometric assessments: Initial descriptives. Addiction, 105(2), 226-239. Pirro, V., Valente, V., Oliveri, P., De Bernardis, A., Salomone, A., & Vincenti, M. (2011). Chemometric evaluation of nine alcohol biomarkers in a large population of clinically-classified subjects: Pre-eminence of ethyl glucuronide concentration in hair for confirmatory classification. Analytical and Bioanalytical Chemistry, 401, 2153-2164. doi: 10.1007/s00216-011-5314-7 Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 6